The Research Committee of the Bellvitge Hospital held on 30 June the 2022 Research Session, during which the several grants for clinical research projects, intensification for pre-doctoral professionals and post-residency training were awarded.
The welcome was given by Dr Encarna Grifell, Director of Strategic Planning, Innovation and Evaluation of the GTMS; Dr Josep Comin, Chairman of the Research Committee of the HUB; and, Dr Fernando Fernández Aranda, Scientific Director of IDIBELL.
Prior to the presentation of the grants, the results of the two research projects corresponding to the year 2017, which have already been completed, were presented.
Dr Isabel Leiva Badosa, from the Pharmacy Service, shared the conclusions of the randomised, double-blind, pilot clinical trial to compare the efficacy and safety of intravenous fish oil lipid emulsions in adult hospitalised patients treated with total parenteral nutrition with hypertriglyceridaemia.
For his part, Dr Alejandro Fernández Coello presented the results of the research project that he has developed in the Neurosurgery Department: Mapping memory, improving the diagnosis of hippocampal functional reserve in patients with pharmacoresistant epilepsy.
The grant for clinical research projects 2021 was awarded to Dr Marta Clemente Agustín, from General and Digestive Surgery.
Furthermore, the intensification grants for pre-doctoral health professionals 2022 were collected by Samantha Aso González (Pneumology), Eva Benavent Palomares (Home hospitalisation), Esther Calero Molina (UMICO Cardiology Nurse) and Alexandre Favà Buch (Nephrology).
The delivery of the grants was closed with those corresponding to the HUB-IDIBELL Research Committee Programme for Postresidency Training in Research, which were collected by Carlos Couceiro Monteagudo, from the Nephrology Service, and Benet Villanueva Cutillas, from Internal Medicine.
The research session included a lecture on the application of artificial intelligence in medicine by Dr Carolina García-Vidal, a specialist in the Infectious Diseases Service of Barcelona’s Hospital Clínic and lecturer at the UB.
Dr García Vidal, who worked for ten years in the Infectious Diseases Service of the HUB, explained in a practical way in what manner they are using the computational capacity of BigData to improve clinical decisions. It should be borne in mind that "nobody has more data than what we produce and collect in the medical services," he said. This provides a potential that has made it possible, for instance, to identify that the disease caused by SARS-CoV-2 had different forms of severity. Using a trillion pieces of data collected from COVID-19 patients in just three months, it was possible to replace subjectivity with objective data and identify patterns in patients' blood, which facilitated personalised treatment and a 50% reduction in mortality.